Ontology highlight
ABSTRACT: Background
Recommendations for blood cholesterol management differ across different guidelines.Hypothesis
Lipid-lowering strategies based on low-density lipoprotein-cholesterol (LDL-c) percent reduction or target concentration may have different effects on the expected cardiovascular benefit in intermediate-risk individuals.Methods
We selected individuals between 40 and 75?years of age with 10-year risk for atherosclerotic cardiovascular disease (ASCVD) between 5.0% and <7.5% who underwent a routine health screening. For every subject, we simulated a strategy based on a 40% LDL-c reduction (S40% ) and another strategy based on achieving LDL-c target ?100?mg/dL (Starget-100 ). The cardiovascular benefit was estimated assuming a 22% relative risk reduction in major cardiovascular events for each 39?mg/dL of LDL-c lowered.Results
The study comprised 1756 individuals (94% men, 52?±?5?years old). LDL-c and predicted 10-year ASCVD risk would be slightly lower in S40% compared to Starget-100 . The number needed to treat to prevent 1 major cardiovascular event in 10?years (NNT10 ) would be 56 with S40% and 66 with Starget-100 . S40% would prevent more events in individuals with lower baseline LDL-c, whereas Starget-100 would be more protective in those with higher LDL-c. A dual-target strategy (40% minimum LDL-c reduction and achievement of LDL-c??100?mg/dL) would be associated with outcomes similar to those expected with the S40% (NNT10 =?55).Conclusions
In an intermediate-risk population, cardiovascular benefit from LDL-c lowering may be optimized by tailoring the treatment according to the baseline LDL-c or by setting a dual-target strategy (fixed dose statin plus achievement of target LDL-c concentration).
SUBMITTER: Cesena FHY
PROVIDER: S-EPMC6489793 | biostudies-literature | 2018 Mar
REPOSITORIES: biostudies-literature
Cesena Fernando H Y FHY Laurinavicius Antonio Gabriele AG Valente Viviane A VA Conceição Raquel D RD Santos Raul D RD Bittencourt Marcio S MS
Clinical cardiology 20180325 3
<h4>Background</h4>Recommendations for blood cholesterol management differ across different guidelines.<h4>Hypothesis</h4>Lipid-lowering strategies based on low-density lipoprotein-cholesterol (LDL-c) percent reduction or target concentration may have different effects on the expected cardiovascular benefit in intermediate-risk individuals.<h4>Methods</h4>We selected individuals between 40 and 75 years of age with 10-year risk for atherosclerotic cardiovascular disease (ASCVD) between 5.0% and < ...[more]